Vilacto Bio Inc. (OTCPK:VIBI) announced that it has entered into a security purchase agreement for the private placement of convertible promissory note for gross proceeds of $167,750 on February 26, 2018. The transaction will include participation from new investor Auctus Fund, LLC; a fund managed by Auctus Private Equity Management, Inc. The note will bear interest at the rate of 12% per annum and mature on November 26, 2018. The note will be convertible into common shares. In connection with the transaction, the company will pay transaction expenses of $15,000 and $2,750 for investor’s legal expenses. The securities will be issued pursuant to exemption provided under Regulation D.